Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Introduction to Language of Pathophysiology ll01:17

Introduction to Language of Pathophysiology ll

This lesson explores key terms that describe how diseases progress, their outcomes, and their distribution in populations.Diagnostic tests identify diseases and monitor treatment. These include blood and urine tests, biopsies, imaging (X-ray, MRI), and detection of infectious agents.Remission is a reduction or disappearance of symptoms.Exacerbation refers to the worsening of symptoms, such as increased wheezing during an asthma attack.A precipitating factor triggers an acute episode, while a...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Infectious diseases and blood supply safety in the United States in 2026: A review.

The American journal of medicine·2026
Same author

Vaccines for International Travelers: Current Status and Recent Developments.

The American journal of medicine·2025
Same author

The kinetoplast in the diagnosis of visceral leishmaniasis.

IDCases·2022
Same author

Fly bites and skin lesion in an asymptomatic traveler returned from Tanzania: Next steps?

IDCases·2022
Same author

Case Report: COVID-19 Misdiagnosed as a Drug Reaction to Miltefosine.

The American journal of tropical medicine and hygiene·2021
Same author

Miltefosine Treatment of Cutaneous Leishmaniasis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020

関連する実験動画

Updated: Jul 8, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

リーシュマニア症の治療における進歩

Henry W Murray1, Jonathan D Berman, Clive R Davies

  • 1Department of Medicine, Weill Medical College of Cornell University, New York, USA. hwmurray@med.cornell.edu

Lancet (London, England)
|November 1, 2005
PubMed
まとめ
この要約は機械生成です。

リーシュマニア症は,皮膚病変から内臓病に至るまで,さまざまな臨床形態を呈し,治療にも関わらず生涯にわたって持続することが多い. 制御の課題には,ベクトル管理の制限,ワクチンの欠如,薬剤耐性などがあり,効果的な予防と治療を妨げています.

さらに関連する動画

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

関連する実験動画

Last Updated: Jul 8, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

科学分野:

  • 医学寄生虫学 医学寄生虫学
  • 免疫学 免疫学とは
  • 感染症 感染症は感染症です.

背景:

  • 寄生病であるリーシュマニア症は,宿主-寄生虫の相互作用と免疫反応の影響を受ける広範な臨床スペクトルを示しています.
  • 感染は,無症状から局所的な皮膚,粘膜,内臓の形態まであり,地域や宿主の免疫によって結果が異なります.
  • 免疫反応と治療にもかかわらず,細胞内寄生虫はマクロファージ内で生涯持続し,慢性または再発性感染症につながる可能性があります.

研究 の 目的:

  • リーシュマニア症の臨床スペクトル,診断,治療に関する包括的な概要を提供する.
  • リーシュマニア症の予防と管理における課題と障害を強調し,特に流行地域におけるリーシュマニア症の予防と管理を強調する.
  • 薬剤耐性に対する新たな治療戦略について議論する.

主な方法:

  • リーシュマニア症の臨床表現と流行病学的パターンのレビュー.
  • 顕微鏡検査,血清検査,培養,DNA検出を含む診断方法の要約.
  • リーシュマニア症に対する従来の治療法と新しい治療法の分析.

主要な成果:

  • リーシュマニア症は,サブ臨床的,局所的,拡散的な形態で現れ,プレゼンテーションと流行性の大きな地域差異があります.
  • 診断は,寄生虫の可視化,血清学,培養,DNA検出に依存し,検査方法はより高い感度を提供します.
  • ペンタヴァレントアンチモンは依然として主要な治療法ですが,薬剤耐性にはアンフォテリシンB,パロモミシン,ミルテフォシンなどの代替治療が必要になりました.

結論:

  • リーシュマニア症のコントロールは,貧困,不十分な砂媒介者制御,ワクチンの欠如,そして手頃な価格の薬の不十分な開発などの要因によって妨げられています.
  • 診断と治療の進歩にもかかわらず,リーシュマニア症は,統合された制御戦略を必要とする,見過ごされている熱帯病です.
  • 薬剤耐性に対処し,効果的な治療へのアクセスを改善することは,世界的にリーシュマニア症の管理に不可欠です.